Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd

Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...

書誌詳細
主要な著者:	Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere
フォーマット:	論文
言語:	English
出版事項:	Taylor & Francis Group 2017-04-01
シリーズ:	Expert Review of Vaccines
主題:	rabivax-s rabies purified vero cell rabies vaccine safety immunogenicity
オンライン･アクセス:	http://dx.doi.org/10.1080/14760584.2017.1294068

類似資料

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
著者:: Piyada Angsuwatcharakon, 等
出版事項: (2018-02-01)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
著者:: Jia Li, 等
出版事項: (2024-12-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
著者:: D.J. Briggs, 等

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
著者:: Jing Wang, 等
出版事項: (2017-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
著者:: A. L. Kravtsov, 等
出版事項: (2019-08-01)

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
著者:: Hua-Kun Lv, 等
出版事項: (2025-02-01)

Study on immune persistence of the CTN-1V strain rabies vaccine in humans
著者:: Lidong Wang, 等
出版事項: (2024-03-01)

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis
著者:: Scott Preiss, 等
出版事項: (2018-06-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
著者:: Nianmin Shi, 等
出版事項: (2017-06-01)

Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
著者:: Zheng-Gang Zhu, 等
出版事項: (2018-11-01)

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine
著者:: Jia Li, 等
出版事項: (2024-12-01)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposureResearch in context
著者:: Gagandeep Kang, 等
出版事項: (2023-07-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
著者:: Pornthep Chanthavanich, 等
出版事項: (2018-04-01)

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures
著者:: Xiaohong Wu, 等
出版事項: (2023-08-01)

Infection and Prevention of Rabies Viruses
著者:: Shiu-Jau Chen, 等
出版事項: (2025-02-01)

Development of mRNA rabies vaccines
著者:: Zixin Fang, 等
出版事項: (2024-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
著者:: Thomas Moulenat, 等
出版事項: (2020-03-01)

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
著者:: Zhenzhen Liang, 等
出版事項: (2024-11-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
著者:: Lei Zhang, 等
出版事項: (2021-08-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
著者:: S. V. Generalov, 等
出版事項: (2017-10-01)

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial
著者:: Xingyu Zhou, 等
出版事項: (2019-04-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
著者:: Heng Shen, 等
出版事項: (2021-02-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
著者:: E. G. Abramova, 等
出版事項: (2019-11-01)

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
著者:: Pooneh Rahimi, 等
出版事項: (2014-08-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
著者:: Xiaoyuan Huang, 等
出版事項: (2023-01-01)

Retrospective study of rabies epidemiology in Ukraine (1950-2019)
著者:: I. F. Makovska, 等
出版事項: (2020-03-01)

Management of rabies
著者:: J. Weyer, 等
出版事項: (2019-07-01)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
著者:: Irina Matveeva, 等
出版事項: (2022-09-01)

The Formation of the Eastern Africa Rabies Network: A Sub-Regional Approach to Rabies Elimination
著者:: Emily G Pieracci, 等
出版事項: (2017-07-01)

Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings
著者:: Sunil Karande, 等
出版事項: (2015-07-01)

A case of human rabies in the Urban Area of Ribeirão Preto, SP, Brazil
著者:: SILVA Jorgete M., 等
出版事項: (1997-01-01)

A case of human survival of rabies, South Africa
著者:: Jacqueline Weyer, 等
出版事項: (2016-07-01)

Factors related to vaccines for both patients exposed with rabies and dogs
著者:: Lam Quy Ngo, 等
出版事項: (2022-03-01)

Factors related to vaccines for both patients exposed with rabies and dogs
著者:: Lam Quy Ngo, 等
出版事項: (2022-03-01)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
著者:: Jun Luo, 等
出版事項: (2020-04-01)

MANAJEMEN INFEKSI RABIES BERISIKO TINGGI: STUDI KASUS TANPA SERUM ANTI-RABIES
著者:: Mahdika Ambarwaty, 等
出版事項: (2023-12-01)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study
著者:: Gadey Sampath, 等
出版事項: (2017-07-01)

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine
著者:: Anurag Agarwal, 等
出版事項: (2022-11-01)

The Role of the Gray Wolf in Rabies Transmission in Iran and Preliminary Assessment of an Oral Rabies Vaccine in this Animal
著者:: Alireza Gholami, 等
出版事項: (2017-07-01)

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
著者:: Weerawan Hattasingh, 等
出版事項: (2022-01-01)